Regeneron (REGN) Tops Q4 EPS by 80c
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $797.99 --0%
Financial Fact:
Net loss before income tax benefit: 365.88M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Net loss before income tax benefit: 365.88M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q4 EPS of $12.07, $0.80 better than the analyst estimate of $11.27. Revenue for the quarter came in at $3.79 billion versus the consensus estimate of $3.76 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Arcos Dorados (ARCO) Tops Q2 EPS by 7c
- Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
